The relationship between chimeric RNAs and gene fusions: Potential implications of reciprocity in cancer

Abel, H.J., Larson, D.E., Chiang, C., Das, I., Kanchi, K.L., Layer, R.M., Neale, B.M., Salerno, W.J., Reeves, C., Buyske, S., Genomics, N.C. for C.D., Matise, T.C., Muzny, D.M., Zody, M.C., Lander, E.S., Dutcher, S.K., Stitziel, N.O., Hall, I.M., 2018. Mapping and characterization of structural variation in 17,795 deeply sequenced human genomes. bioRxiv 508515.

Akiva, P., Toporik, A., Edelheit, S., Peretz, Y., Diber, A., Shemesh, R., Novik, A., Sorek, R., 2006. Transcription-mediated gene fusion in the human genome. Genome Res. 16, 30-36.

Anderson, R.M., Sumption, N.D., Papworth, D.G., Goodhead, D.T., 2006. Chromosome breakpoint distribution of damage induced in peripheral blood lymphocytes by densely ionizing radiation. Int. J. Radiat. Biol. 82, 49-58.

Ann Boija, A., Klein, I.A., Sabari, B.R., Ihn Lee, T., Taatjes, D.J., Young Correspondence, R.A., 2018. Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains In Brief Activation domains from a diverse array of mammalian and yeast transcription factors form phase-separated condensates with Mediator to activate gene expression. Cell 175, 1842-1855.e16.

Arlt, M.F., Durkin, S.G., Ragland, R.L., Glover, T.W., 2006. Common fragile sites as targets for chromosome rearrangements. DNA Repair 5, 1126–1135.

Babiceanu, M., Qin, F., Xie, Z., Jia, Y., Lopez, K., Janus, N., Facemire, L., Kumar, S., Pang, Y., Qi, Y., Lazar, I.M., Li, H., 2016. Recurrent chimeric fusion RNAs in non-cancer tissues and cells. Nucleic Acids Res. 44, 2859-2872.

Balamurali, D., Gorohovski, A., Detroja, R., Palande, V., Raviv-Shay, D., Frenkel-Morgenstern, M., 2019. ChiTaRS 5.0: the comprehensive database of chimeric transcripts matched with druggable fusions and 3D chromatin maps. Nucleic Acids Res.

Barresi, V., Cosentini, I., Scuderi, C., Napoli, S., Di Bella, V., Spampinato, G., Condorelli, D.F., 2019. Fusion transcripts of adjacent genes: New insights into the world of human complex transcripts in cancer. Int. J. Mol. Sci. 20.

Burrow, A.A., Williams, L.E., Pierce, L.C., Wang, Y.-H., 2009. Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics 10, 59.

Canela, A., Maman, Y., Jung, S., Wong, N., Callen, E., Day, A., Kieffer-Kwon, K.R., Pekowska, A., Zhang, H., Rao, S.S.P., Huang, S.C., Mckinnon, P.J., Aplan, P.D., Pommier, Y., Aiden, E.L., Casellas, R., Nussenzweig, A., 2017. Genome Organization Drives Chromosome Fragility. Cell 170, 507-521.e18.

Cao, L., Yu, Y., Bilke, S., Walker, R.L., Mayeenuddin, L.H., Azorsa, D.O., Yang, F., Pineda, M., Helman, L.J., Meltzer, P.S., 2010. Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res. 70, 6497-6508.

Chase, A., Ernst, T., Fiebig, A., Collins, A., Grand, F., Erben, P., Reiter, A., Schreiber, S., Cross, N.C.P., 2010. TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals. Haematologica 95, 20-26.

Chiang, C., Scott, A.J., Davis, J.R., Tsang, E.K., Li, X., Kim, Y., Hadzic, T., Damani, F.N., Ganel, L., Montgomery, S.B., Battle, A., Conrad, D.F., Hall, I.M., Hall, I.M., 2017. The impact of structural variation on human gene expression. Nat. Genet. 49, 692-699.

Chwalenia, K., Facemire, L., Li, H., 2017. Chimeric RNAs in cancer and normal physiology. Wiley Interdiscip. Rev. RNA 8, p. e1427.

Chwalenia, K., Qin, F., Singh, S., Li, H., 2019. A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes. Nucleic Acids Res. 47, e24-e24.

Cisse, I.I., Izeddin, I., Causse, S.Z., Boudarene, L., Senecal, A., Muresan, L., Dugast-Darzacq, C., Hajj, B., Dahan, M., Darzacq, X., 2013. Real-time dynamics of RNA polymerase II clustering in live human cells. Science (80-. ). 341, 664-667.

Cuzick, J., 2017. Preventive therapy for cancer. Lancet Oncol.

Demichelis, F., Rubin, M.A., 2007. TMPRSS2-ETS fusion prostate cancer: biological and clinical implications. J. Clin. Pathol. 60, 1185-1186.

Devassy, J.G., Nwachukwu, I.D., Jones, P.J.H., 2015. Curcumin and cancer: Barriers to obtaining a health claim. Nutr. Rev. 73, 155-165.

Dillon, L.W., Pierce, L.C.T., Lehman, C.E., Nikiforov, Y.E., Wang, Y.-H., 2013. DNA Topoisomerases Participate in Fragility of the Oncogene RET. PLoS One 8, 75741.

Dixon, J.R., Jung, I., Selvaraj, S., Shen, Y., Antosiewicz-Bourget, J.E., Lee, A.Y., Ye, Z., Kim, A., Rajagopal, N., Xie, W., Diao, Y., Liang, J., Zhao, H., Lobanenkov, V. V., Ecker, J.R., Thomson, J.A., Ren, B., 2015. Chromatin architecture reorganization during stem cell differentiation. Nature 518, 331-336.

Dorn, R., Reuter, G., Loewendorf, A., 2001. Transgene analysis proves mRNA trans-splicing at the complex mod(mdg4) locus in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 98, 9724-9729.

Durrens, P., Nikolski, M., Sherman, D., 2008. Fusion and fission of genes define a metric between fungal genomes. PLoS Comput. Biol. 4.

Edwards, P.A.W., 2010. Fusion genes and chromosome translocations in the common epithelial cancers. J. Pathol.

Elfman, J., Li, H., 2018. Chimeric RNA in Cancer and Stem Cell Differentiation. Stem Cells Int. 2018, 3178789.

Engreitz, J.M., Agarwala, V., Mirny, L.A., 2012. Three-Dimensional Genome Architecture Influences Partner Selection for Chromosomal Translocations in Human Disease. PLoS One 7, e44196.

Ezoe, S., 2012. Secondary Leukemia Associated with the Anti-Cancer Agent , Etoposide , a Topoisomerase II Inhibitor 2444-2453.

Forabosco, A., Percesepe, A., Santucci, S., 2009. Incidence of non-age-dependent chromosomal abnormalities: A population-based study on 88965 amniocenteses. Eur. J. Hum. Genet. 17, 897-903.

Gandhi, M., Dillon, L.W., Pramanik, S., Nikiforov, Y.E., Wang, Y.-H., 2010. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene 29, 2272-2280.

Ghamari, A., van de Corput, M.E.P.C., Thongjuea, S., Van Cappellen, W.A., Van Ijcken, W., Van Haren, J., Soler, E., Eick, D., Lenhard, B., Grosveld, F.G., 2013. In vivo live imaging of RNA polymerase II transcription factories in primary cells. Genes Dev. 27, 767-777.

Gingeras, T.R., 2009. Implications of chimaeric non-co-linear transcripts. Nature 461, 206-211.

Glover, T.W., Berger, C., Coyle, J., Echo, B., 1984. DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67, 136-142.

Gothe, H.J., Bouwman, B.A.M., Gusmao, E.G., Piccinno, R., Petrosino, G., Sayols, S., Drechsel, O., Minneker, V., Josipovic, N., Mizi, A., Nielsen, C.F., Wagner, E.M., Takeda, S., Sasanuma, H., Hudson, D.F., Kindler, T., Baranello, L., Papantonis, A., Crosetto, N., Roukos, V., 2019. Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations. Mol. Cell 75, 267-283.e12.

Graf Finckenstein, F., Shahbazian, V., Davicioni, E., Ren, Y.-X., Anderson, M.J., 2008. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Oncogene 27, 2004-2014.

Greger, L., Su, J., Rung, J., Ferreira, P.G., Lappalainen, T., Dermitzakis, E.T., Brazma, A., 2014. Tandem RNA chimeras contribute to transcriptome diversity in human population and are associated with intronic genetic variants. PLoS One 9.

Gryder, B.E., Yohe, M.E., Chou, H.-C., Zhang, X., Marques, J., Wachtel, M., Sen, N., Song, Y.,Gualtieri, A., Pomella, S., Rota, R., Cleveland, A., Wen, X., Sindiri, S., Wei, J.S., Barr, F.G., Das, S.,Andresson, T., Guha, R., Lal-Nag, M., Ferrer, M., Shern, J.F., Zhao, K., Thomas, C.J., Khan, J., 2017. PAX3-FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability. Cancer Discov. 7,884–899

Gupta, S.K., Luo, L., Yen, L., 2018. RNA-mediated gene fusion in mammalian cells. Proc. Natl. Acad. Sci. 115, E12295-E12304.

Hantschel, O., Rix, U., Superti-Furga, G., 2008. Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk. Lymphoma 49, 615-619.

He, M., Li, Y., Tang, Q., Li, D., Jin, L., Tian, S., Che, T., He, S., Deng, L., Gao, G., Gu, Y., Jiang, Z., Li, X., Li, M., 2018. Genome-Wide Chromatin Structure Changes During Adipogenesis and Myogenesis. Int. J. Biol. Sci. 14, 1571-1585.

Huettner, C.S., Zhang, P., Van Etten, R.A., Tenen, D.G., 2000. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24, 57-60.

Jang, Y.E., Jang, I., Kim, Sunkyu, Cho, S., Kim, D., Kim, K., Kim, Jaewon, Hwang, J., Kim, Sangok, Kim, Jaesang, Kang, J., Lee, B., Lee, S., 2019. ChimerDB 4.0: an updated and expanded database of fusion genes. Nucleic Acids Res.

Janz, S., Potter, M., Rabkin, C.S., 2003. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes, Chromosom. Cancer 36, 211-223.

Jividen, K., Li, H., 2014. Chimeric RNAs generated by intergenic splicing in normal and cancer cells. Genes, Chromosom. Cancer 53, 963-971.

Johnston, J.M., Carroll, W.L., 1992. C-myc hypermutation in burkitt’s lymphoma. Leuk. Lymphoma 8, 431-439.

Kaiser, V.B., Semple, C.A., 2018. Chromatin loop anchors are associated with genome instability in cancer and recombination hotspots in the germline. Genome Biol. 19.

Kandel, E.S., Nudler, E., 2002. Template switching by RNA polymerase II in vivo. Evidence and implications from a retroviral system. Mol. Cell 10, 1495-1502.

Keskin, H., Meers, C., Storici, F., 2016. Transcript RNA supports precise repair of its own DNA gene. RNA Biol. 13, 157-165.

Keskin, H., Shen, Y., Huang, F., Patel, M., Yang, T., Ashley, K., Mazin, A. V., Storici, F., 2014. Transcript-RNA-templated DNA recombination and repair. Nature 515, 436-439.

Khan, J., Bittner, M.L., Saal, L.H., Teichmann, U., Azorsa, D.O., Gooden, G.C., Pavan, W.J., Trent, J.M., Meltzer, P.S., 1999. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. U. S. A. 96, 13264-13269.

Khan, J., Simon, R., Bittner, M., Chen, Y., Leighton, S.B., Pohida, T., Smith, P.D., Jiang, Y., Gooden, G.C., Trent, J.M., Meltzer, P.S., 1998. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009-5013.

Koontz, J.I., Soreng, A.L., Nucci, M., Kuo, F.C., Pauwels, P., van Den Berghe, H., Dal Cin, P., Fletcher, J.A., Sklar, J., 2001. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc. Natl. Acad. Sci. U. S. A. 98, 6348-6353.

Kowarz, E., Merkens, J., Karas, M., Dingermann, T., Marschalek, R., 2011. Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer. Am. J. Blood Res. 1, 1-12.

Kubo, T., Shimose, S., Fujimori, J., Furuta, T., Ochi, M., 2015. Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis. Crit. Rev. Oncol. Hematol.

Kumar-Sinha, C., Kalyana-Sundaram, S., Chinnaiyan, A.M., 2012. SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing. Cancer Discov. 2, 582-585.

Lagutina, I.V., Valentine, V., Picchione, F., Harwood, F., Valentine, M.B., Villarejo-Balcells, B., Carvajal, J.J., Grosveld, G.C., 2015. Modeling of the human alveolar rhabdomyosarcoma Pax3-Foxo1 chromosome translocation in mouse myoblasts using CRISPR-Cas9 Nuclease. PLoS Genet. 11, e1004951.

Lehman, C.E., Dillon, L.W., Nikiforov, Y.E., Wang, Y.H., 2017. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements. Carcinogenesis 38, 293-301.

Leonard, G., Richards, T.A., 2012. Genome-scale comparative analysis of gene fusions, genefissions, and the fungal tree of life. Proc. Natl. Acad. Sci. U. S. A. 109, 21402-21407.

Li, Z., Qin, F., Li, H., 2018. Chimeric RNAs and their implications in cancer. Curr. Opin. Genet. Dev.

Li, H., Wang, J., Mor, G., Sklar, J., 2008. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science 321, 1357-1361.

Li, H., Ma, X., Wang, J., Koontz, J., Nucci, M., Sklar, J., 2007. Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival. Proc. Natl. Acad. Sci. U. S. A. 104, 20001-6.

Li, X., Zhao, L., Jiang, H., Wang, W., 2009. Short Homologous Sequences Are Strongly Associated with the Generation of Chimeric RNAs in Eukaryotes. J. Mol. Evol. 68, 56-65.

Lieberman-Aiden, E., Van Berkum, N.L., Williams, L., Imakaev, M., Ragoczy, T., Telling, A., Amit, I., Lajoie, B.R., Sabo, P.J., Dorschner, M.O., Sandstrom, R., Bernstein, B., Bender, M.A., Groudine, M., Gnirke, A., Stamatoyannopoulos, J., Mirny, L.A., Lander, E.S., Dekker, J., 2009. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science (80-. ). 326, 289-293.

Linardic, C.M., 2008. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 270, 10-18.

Lomvardas, S., Barnea, G., Pisapia, D.J., Mendelsohn, M., Kirkland, J., Axel, R., 2006. Interchromosomal Interactions and Olfactory Receptor Choice. Cell 126, 403-413.

Lopez-Nieva, P., Fernandez-Navarro, P., Grana-Castro, O., Andres-Leon, E., Santos, J., Villa-Morales, M., Cobos-Fernandez, M.A., Gonzalez-Sanchez, L., Malumbres, M., Salazar-Roa, M., Fernandez-Piqueras, J., 2019. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma. Sci. Rep. 9, 5179.

Ma, X., Wang, Jinglan, Wang, Jianhui, Ma, C.X., Gao, X., Patriub, V., Sklar, J.L., 2017. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis. Oncotarget 8, 4062-4078.

Maher, C.A., Kumar-Sinha, C., Cao, X., Kalyana-Sundaram, S., Han, B., Jing, X., Sam, L., Barrette, T., Palanisamy, N., Chinnaiyan, A.M., 2009. Transcriptome sequencing to detect gene fusions in cancer. Nature 458, 97-101.

Mani, R.S., Tomlins, S.A., Callahan, K., Ghosh, A., Nyati, M.K., Varambally, S., Palanisamy, N., Chinnalyan, A.M., 2009. Induced chromosomal proximity and gene fusions in prostate cancer. Science (80-. ).

Mazina, O.M., Keskin, H., Hanamshet, K., Storici, F., Mazin, A. V, 2017. Rad52 Inverse Strand Exchange Drives RNA-Templated DNA Double-Strand Break Repair. Mol. Cell 67, 19-29.e3.

McDevitt, S., Rusanov, T., Kent, T., Chandramouly, G., Pomerantz, R.T., 2018. How RNA transcripts coordinate DNA recombination and repair. Nat. Commun. 9, 1091.

McManus, C.J., Duff, M.O., Eipper-Mains, J., Graveley, B.R., 2010. Global analysis of trans-splicing in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 107, 12975-12979.

McStay, B., Grummt, I., 2008. The epigenetics of rRNA genes: from molecular to chromosome biology. Annu. Rev. Cell Dev. Biol. 24, 131–157.

Mertens, F., Tayebwa, J., 2014. Evolving techniques for gene fusion detection in soft tissue tumours. Histopathology 64, 151-162.

Mitelman, F., Johansson, B., Mertens, F., 2007. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer.

Mitelman, F., Johansson, B., & Mertens, F., 2012. Mitelman database of chromosome aberrations and gene fusions in cancer. https://mitelmandatabase.isb-cgc.org.

Missiaglia, E., Williamson, D., Chisholm, J., Wirapati, P., Pierron, G., Petel, F., Concordet, J.-P., Thway, K., Oberlin, O., Pritchard-Jones, K., Delattre, O., Delorenzi, M., Shipley, J., 2012. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J. Clin. Oncol. 30, 1670-1677.

Monahan, K., Horta, A., Lomvardas, S., 2019. LHX2- and LDB1-mediated trans interactions regulate olfactory receptor choice. Nature 565, 448-453.

Negri, E., La Vecchia, C., Franceschi, S., D’Avanzo, B., Parazzini, F., 1991. Vegetable and fruit consumption and cancer risk. Int. J. Cancer 48, 350-354.

Neves, H., Ramos, C., Gomes Da Silva, M., Parreira, A., Parreira, L., 1999. The nuclear topography of ABL, BCR, PML, and RARα genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93, 1197-1207.

Nikiforov, Y., Nikiforov, Y.E., 2002. RET/PTC Rearrangement in Thyroid Tumors, Endocrine Pathology. 13, 3-16.

Nikiforova, M.N., Stringer, J.R., Blough, R., Medvedovic, M., Fagin, J.A., Nikiforov, Y.E., 2000. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290, 138-141.

Nowacki, M., Vijayan, V., Zhou, Y., Schotanus, K., Doak, T.G., Landweber, L.F., 2008. RNA-mediated epigenetic programming of a genome-rearrangement pathway. Nature 451, 153-158.

Osborne, C.S., 2014. Molecular pathways: Transcription factories and chromosomal translocations. Clin. Cancer Res. 20, 296-300.

Panigrahi, P., Jere, A., Anamika, K., 2018. FusionHub: A unified web platform for annotation and visualization of gene fusion events in human cancer. PLoS One 13, e0196588.

Pasek, S., Risler, J.-L.J.L., Brezellec, P., Brezellec, P., 2006. Gene fusion/fission is a major contributor to evolution of multi-domain bacterial proteins. Bioinformatics 22, 1418-1423.

Qin, F., Shi, X., Li, H., 2020. Knockdown of chimeric RNA by RNAi. In: Methods in Molecular Biology. Humana Press Inc., pp. 143-154.

Qin, F., Song, Z., Babiceanu, M., Song, Y., Facemire, L., Singh, R., Adli, M., Li, H., 2015. Discovery of CTCF-sensitive Cis-spliced fusion RNAs between adjacent genes in human prostate cells. PLoS Genet. 11, e1005001.

Qin, F., Song, Z., Chang, M., Song, Y., Frierson, H., Li, H., 2016. Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer. Cancer Lett. 380, 39-46.

Qin, F., Zhang, Y., Liu, J., Li, H., 2017. SLC45A3-ELK4 functions as a long non-coding chimeric RNA. Cancer Lett. 404, 53-61.

Rao, S.S.P., Huntley, M.H., Durand, N.C., Stamenova, E.K., Bochkov, I.D., Robinson, J.T., Sanborn, A.L., Machol, I., Omer, A.D., Lander, E.S., Aiden, E.L., 2014. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665-1680.

Ren, R., 2005. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 5, 172-183.

Rickman, D.S., Pflueger, D., Moss, B., VanDoren, V.E., Chen, C.X., de la Taille, A., Kuefer, R., Tewari, A.K., Setlur, S.R., Demichelis, F., Rubin, M.A., 2009. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res. 69, 2734-2738.

Roukos, V., Voss, T.C., Schmidt, C.K., Lee, S., Wangsa, D., Misteli, T., 2013. Spatial dynamics of chromosome translocations in living cells. Science (80-. ). 341, 660-664.

Rowley, J.D., Blumenthal, T., 2008. The Cart Before the Horse. Science (80-. ). 321, 1302-1304.

Ruffle, F., Audoux, J., Boureux, A., Beaumeunier, S., Gaillard, J.-B., Bou Samra, E., Megarbane, A., Cassinat, B., Chomienne, C., Alves, R., Riquier, S., Gilbert, N., Lemaitre, J.-M., Bacq-Daian, D., Bouge, A.L., Philippe, N., Commes, T., 2017. New chimeric RNAs in acute myeloid leukemia. F1000Research 6, 1302.

Sandberg, A.A., 2007. The cytogenetics and molecular biology of endometrial stromal sarcoma. Cytogenet. Genome Res. 118, 182-189.

Setten, R.L., Rossi, J.J., Han, S. ping, 2019. The current state and future directions of RNAi-based therapeutics. Nat. Rev. Drug Discov.

Shaw, A.T., Yeap, B.Y., Solomon, B.J., Riely, G.J., Gainor, J., Engelman, J.A., Shapiro, G.I., Costa, D.B., Ou, S.-H.I., Butaney, M., Salgia, R., Maki, R.G., Varella-Garcia, M., Doebele, R.C., Bang, Y.-J., Kulig, K., Selaru, P., Tang, Y., Wilner, K.D., Kwak, E.L., Clark, J.W., Iafrate, A.J., Camidge, D.R., 2011. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet. Oncol. 12, 1004-1012.

Shen, Y., Nandi, P., Taylor, M.B., Stuckey, S., Bhadsavle, H.P., Weiss, B., Storici, F., 2011. RNA-driven genetic changes in bacteria and in human cells. Mutat. Res. - Fundam. Mol. Mech. Mutagen. 717, 91-98.

Shipley, J., Martins, A.S., Olmos, D., Missiaglia, E., 2011. Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: Rationale and future perspectives. Sarcoma.

Singh, S., Qin, F., Kumar, S., Elfman, J., Lin, E., Pham, L.-P., Yang, A., Li, H., 2020. The landscape of chimeric RNAs in non-diseased tissues and cells. Nucleic Acids Res.

Soda, M., Choi, Y.L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.I., Watanabe, H., Kurashina, K., Hatanaka, H., Bando, M., Ohno, S., Ishikawa, Y., Aburatani, H., Niki, T., Sohara, Y., Sugiyama, Y., Mano, H., 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448, 561-566.

Storici, F., Bebenek, K., Kunkel, T.A., Gordenin, D.A., Resnick, M.A., 2007. RNA-templated DNA repair. Nature 447, 338-341.

Tang, Y., Qin, F., Liu, A., Li, H., 2017. Recurrent fusion RNA DUS4L-BCAP29 in non-cancer human tissues and cells. Oncotarget 8, 31415-31423.

Taylor VI, J.G., Cheuk, A.T., Tsang, P.S., Chung, J.Y., Song, Y.K., Desai, K., Yu, Y., Chen, Q.R., Shah, K., Youngblood, V., Fang, J., Su, Y.K., Yeung, C., Helman, L.J., Mendoza, A., Ngo, V., Staudt, L.M., Wei, J.S., Khanna, C., Catchpoole, D., Qualman, S.J., Hewitt, S.M., Merlino, G., Chanock, S.J., Khan, J., 2009. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J. Clin. Invest. 119, 3395-3407.

Tefferi, A., Skoda, R., Vardiman, J.W., 2009. Myeloproliferative neoplasms: Contemporary diagnosis using histology and genetics. Nat. Rev. Clin. Oncol.

Thys, R.G., Lehman, C.E., Pierce, L.C.T., Wang, Y.-H., 2015. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells. Mutat. Res. Mol. Mech. Mutagen. 779, 86-95.

Tomczak, K., Czerwinska, P., Wiznerowicz, M., 2015. The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Wspolczesna Onkol.

Tomlins, S.A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B.E., Cao, Q., Prensner, J.R., Rubin, M.A., Shah, R.B., Mehra, R., Chinnaiyan, A.M., 2008. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10, 177-188.

Tomlins, S.A., Rhodes, D.R., Perner, S., Dhanasekaran, S.M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J.E., Shah, R.B., Pienta, K.J., Rubin, M.A., Chinnaiyan, A.M., 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648.

Torres-Ruiz, R., Martinez-Lage, M., Martin, M.C., Garcia, A., Bueno, C., Castano, J., Ramirez, J.C., Menendez, P., Cigudosa, J.C., Rodriguez-Perales, S., 2017. Efficient Recreation of t(11;22) EWSR1-FLI1+in Human Stem Cells Using CRISPR/Cas9. Stem Cell Reports 8, 1408-1420.

van Ijzendoorn, D.G.P., de Jong, D., Romagosa, C., Picci, P., Benassi, M.S., Gambarotti, M., Daugaard, S., van de Sande, M., Szuhai, K., Bovee, J.V.M.G., 2015. Fusion events lead to truncation of FOS in epithelioid hemangioma of bone. Genes Chromosom. Cancer 54, 565-574.

Varley, K.E., Gertz, J., Roberts, B.S., Davis, N.S., Bowling, K.M., Kirby, M.K., Nesmith, A.S., Oliver, P.G., Grizzle, W.E., Forero, A., Buchsbaum, D.J., LoBuglio, A.F., Myers, R.M., 2014. Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res. Treat. 146, 287-297.

Velusamy, T., Palanisamy, N., Kalyana-Sundaram, S., Sahasrabuddhe, A.A., Maher, C.A., Robinson, D.R., Bahler, D.W., Cornell, T.T., Wilson, T.E., Lim, M.S., Chinnaiyan, A.M., Elenitoba-Johnson, K.S.J., 2013. Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 110, 3035-3040.

Wang, X., Qiao, Y., Asangani, I.A., Ateeq, B., Poliakov, A., Cieslik, M., Pitchiaya, S., Chakravarthi, B.V.S.K., Cao, X., Jing, X., Wang, C.X., Apel, I.J., Wang, R., Tien, J.C.Y., Juckette, K.M., Yan, W., Jiang, H., Wang, S., Varambally, S., Chinnaiyan, A.M., 2017. Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer. Cancer Cell 31, 532-548.e7.

Williamson, D., Lu, Y.J., Gordon, T., Sciot, R., Kelsey, A., Fisher, C., Poremba, C., Anderson, J., Pritchard-Jones, K., Shipley, J., 2005. Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. J. Clin. Oncol. 23, 880-888.

Wu, P., Yang, S., Singh, S., Qin, F., Kumar, S., Wang, L., Ma, D., Li, H., 2018. The Landscape and Implications of Chimeric RNAs in Cervical Cancer. EBioMedicine 37, 158-167.

Xie, Z., Babiceanu, M., Kumar, S., Jia, Y., Qin, F., Barr, F.G., Li, H., 2016. Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. 113, 13126-13131.

Xie, Z., Li, H., 2017. Fusion RNA profiling provides hints on cell of origin of mysterious tumor. Mol. Cell. Oncol. 4, e1263714.

Xie, Z., Tang, Y., Su, X., Cao, J., Zhang, Y., Li, H., 2019. PAX3-FOXO1 escapes miR-495 regulation during muscle differentiation. RNA Biol. 16, 144-153.

Yan, Z., Huang, N., Wu, W., Chen, W., Jiang, Y., Chen, J., Huang, X., Wen, X., Xu, J., Jin, Q., Zhang, K., Chen, Z., Chien, S., Zhong, S., 2019. Genome-wide colocalization of RNA-DNA interactions and fusion RNA pairs. Proc. Natl. Acad. Sci. 116, 3328-3337.

Yasuhara, T., Kato, R., Hagiwara, Y., Shiotani, B., Yamauchi, M., Nakada, S., Shibata, A., Miyagawa, K., 2018. Human Rad52 Promotes XPG-Mediated R-loop Processing to Initiate Transcription-Associated Homologous Recombination Repair. Cell 175, 558-570.e11.

Yuan, H., Qin, F., Movassagh, M., Park, H., Golden, W., Xie, Z., Zhang, P., Sklar, J., Li, H., 2013. A chimeric RNA characteristic of rhabdomyosarcoma in normal myogenesis process. Cancer Discov. 3, 1394-1403.

Zhang, Y., Gong, M., Yuan, H., Park, H.G., Frierson, H.F., Li, H., 2012. Chimeric transcript generated by cis- splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov. 2, 598-607.

Zhu, D., Singh, S., Chen, X., Zheng, Z., Huang, J., Lin, T., Li, H., 2019. The landscape of chimeric RNAs in bladder urothelial carcinoma. Int. J. Biochem. Cell Biol. 110, 50-58.

Zhu, C., Wu, L., Lv, Y., Guan, J., Bai, X., Lin, J., Liu, T., Yang, X., Robson, S.C., Sang, X., Xue, C., Zhao, H., 2019. The fusion landscape of hepatocellular carcinoma. Mol. Oncol. 13, 1214-1225.